Purpose: We report the results of a controlled survival study in a porcine model investigating Tisseel or a combination of FloSeal and Tisseel in dealing with vascular and collecting-system injury during partial nephrectomy.

Materials And Methods: We performed an open right lower-pole partial nephrectomy on 15 large female pigs. The defect was repaired using standard open techniques (N = 5; controls), Tisseel only (N = 6; group I), or FloSeal followed by Tisseel (N = 4; group II). A Jackson-Pratt drain was placed. Nephrectomy and retrograde pyelography were performed at 1 week.

Results: Operative times were shorter in both study groups, achieving statistical significance in group I (P = 0.008). Warm-ischemia times were significantly improved in both study groups (P = 0.029 and P = 0.00005 in groups I and II, respectively). Time to hemostasis was significantly shorter in group II only (P = 0.002) but approached significance in Group I as well (P = 0.09). Estimated blood loss was not significantly different from the controls in either group. When Tisseel was placed alone after hilar control, hematoma formation under the Tisseel was noted on release of the hilar clamp. After 1 week, there was one urinoma and three urine leaks in the control group. In group I, there was one urinoma and four urine leaks, and there was only one urine leak and no urinomas in group II. There were no hematomas in any of the groups.

Conclusions: Tisseel alone is not adequate for either hemostasis or management of major collecting-system injury. FloSeal capped with Tisseel appears sufficient to control major vascular and collecting-system injuries without adjunctive surgical measures. A proposed technique for laparoscopic partial nephrectomy without reconstructive techniques is presented that warrants clinical study.

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2005.19.1114DOI Listing

Publication Analysis

Top Keywords

floseal tisseel
12
collecting-system injury
12
partial nephrectomy
12
tisseel
10
group
9
controlled survival
8
survival study
8
tisseel combination
8
combination floseal
8
major vascular
8

Similar Publications

Novel Flowable Hemostatic Agent ActiClot: Efficacy and Safety Assessment in Rat and Porcine Models.

J Clin Med

August 2024

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 16419, Republic of Korea.

Article Synopsis
  • The study tested a new hemostatic agent, ActiClot (ATC), comparing its effectiveness and safety against the commercial product FLOSEAL using animal models (rat and porcine).
  • ATC significantly decreased bleeding time in the rat liver model compared to gauze, showing a 70% reduction, and performed similarly to FLOSEAL in both models without major differences in effectiveness.
  • The safety tests indicated ATC is biocompatible and does not cause inflammation, suggesting it could be a viable option for controlling bleeding in surgical and emergency situations.
View Article and Find Full Text PDF

Background: The standard approach to hemostasis during partial nephrectomy (PN) is to perform suture renorrhaphy (SR). Application of a hemostatic bandage (HB) is an alternative to minimize blood loss and devitalized renal parenchyma. We aim to evaluate perioperative outcomes of PN with tumor enucleation (TE) comparing SR to HB.

View Article and Find Full Text PDF

Objective: To demonstrate the noninferiority of the novel hemostatic agent, Hemofence (BMI Korea Co., Ltd., thrombin cross-linked sodium hyaluronate gel matrix) compared to the established agent, Floseal Hemostatic Matrix (Baxter, thrombin-gelatin matrix) in achieving hemostasis for spinal surgeries, with secondary objectives to assess additional efficacy and safety.

View Article and Find Full Text PDF

There are many surgical techniques (packing, Pringle maneuver, etc.) and hemostatic agents to manage hepatic bleeding in trauma surgery. This study compares the effectiveness of two different types of hemostatic agents, one is an active flowable hemostat and the other is a passive hemostat made of modified absorbable polymers [MAP].

View Article and Find Full Text PDF
Article Synopsis
  • The meta-analysis evaluates the effectiveness of Floseal, a thrombin-based hemostatic agent, in reducing blood loss and transfusions during total knee arthroplasty (TKA).
  • Eight randomized controlled trials (RCTs) with a total of 904 patients were included, finding significant reductions in hemoglobin decline and allogenic transfusion risk but no difference in overall blood loss or drainage volume.
  • The study supports the use of Floseal in TKA, recommending further RCTs with extended follow-up to confirm long-term outcomes and safety.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!